本期 13F-HR 中的全部持仓，以及相对上季度的变化。
13F 持仓，最新季度
来源SEC EDGAR13F-HR
FT Options LLC (CIK 1594954) reported $66.4M across 64 reported positions in its SEC 13F filing for 2017-09-30. Largest positions: GWPH ($5.1M, 7.68%), INCY ($4.2M, 6.36%), CLVS ($3.5M, 5.23%), TSRO ($3.4M, 5.15%), TEVA ($2.8M, 4.26%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | GWPH | GW PHARMACEUTICALS PLC | $5.1M | 7.68% | 116,947 | Added |
| 2 | INCY | INCYTE CORP | $4.2M | 6.36% | 119,787 | Added |
| 3 | CLVS | CLOVIS ONCOLOGY INC | $3.5M | 5.23% | 155,587 | Trimmed |
| 4 | TSRO | TESARO INC | $3.4M | 5.15% | 72,262 | Added |
| 5 | TEVA | TEVA PHARMACEUTICAL INDS LTD | $2.8M | 4.26% | 379,823 | New |
| 6 | ALNY | ALNYLAM PHARMACEUTICALS INC | $2.1M | 3.20% | 139,800 | Added |
| 7 | INSM | INSMED INC | $1.8M | 2.77% | 385,453 | Added |
| 8 | VRTX | VERTEX PHARMACEUTICALS INC | $1.8M | 2.71% | 111,700 | Added |
| 9 | BABA | ALIBABA GROUP HLDG LTD | $1.7M | 2.58% | 19,900 | Hold |
| 10 | ICPT | INTERCEPT PHARMACEUTICALS IN | $1.7M | 2.53% | 111,064 | New |
| 11 | AKBA | AKEBIA THERAPEUTICS INC | $1.6M | 2.34% | 220,400 | Added |
| 12 | PBYI | PUMA BIOTECHNOLOGY INC | $1.5M | 2.32% | 25,438 | Trimmed |
| 13 | KMB | KIMBERLY CLARK CORP | $1.4M | 2.06% | 44,300 | Added |
| 14 | ZGNX | ZOGENIX INC | $1.3M | 2.01% | 129,878 | New |
| 15 | IBB | ISHARES TR | $1.3M | 2.00% | 37,162 | Trimmed |
| 16 | KITE | KITE PHARMA INC | $1.3M | 2.00% | 113,500 | Added |
| 17 | PLCE | CHILDRENS PL INC | $1.3M | 2.00% | 34,000 | New |
| 18 | SIOX | AXOVANT SCIENCES LTD | $1.3M | 2.00% | 527,570 | Added |
| 19 | GILD | GILEAD SCIENCES INC | $1.2M | 1.77% | 171,581 | New |
| 20 | NKE | NIKE INC | $1.2M | 1.77% | 40,800 | New |
| 21 | BMY | BRISTOL MYERS SQUIBB CO | $1.1M | 1.61% | 176,900 | Added |
| 22 | HSIC | SCHEIN HENRY INC | $1.1M | 1.59% | 36,148 | New |
| 23 | DBVT | DBV TECHNOLOGIES S A | $1.0M | 1.51% | 127,724 | New |
| 24 | ALXN | ALEXION PHARMACEUTICALS INC | $939,000 | 1.42% | 14,618 | New |
| 25 | ARAV | VERSARTIS INC | $937,000 | 1.41% | 519,940 | New |
来源：SEC 13F 申报文件 · 截至 2017-09-30